Faculty
Judy Chang, MD, MPH
Dr. Chang has been using a variety of qualitative approaches to understand various aspects of substance use disorders including prenatal use of tobacco, opioids, or marijuana.
Renee M. Cloutier, PhD
Dr. Cloutier’s training and research are interdisciplinary, bridging the fields of psychology, prevention science, implementation science, quantitative methods, and public health to achieve two long-term objectives: (1) enhance the measurement of substance use behaviors and problems to ensure the right people, receive the right treatment, at the right time; (2) translate evidence into improved treatment and overdose prevention practices.
Jason Colditz, PhD, MEd
Prior to recently becoming faculty in the division of General Internal Medicine, Dr. Colditz was a research coordinator for over a decade. He also coordinated the Bridging Connections in Addiction Research (BCAR) initiative to foster interdisciplinary research around substance use, addiction, and recovery.
Karlyn Edwards, PhD
One area of Dr. Edwards' research is focused on developing and studying brief digital interventions for opioid misuse/opioid use disorder. She is also interested in characterizing facilitators and barriers to engagement with OUD medications and pschological interventions, including patient experiences of stigma.
Walid F. Gellad, MD, MPH
Director, Center for Pharmaceutical Policy and Prescribing
Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. He has studied opioid use in the veteran population, specifically those receiving care from multiple health systems.
Raagini Jawa, MD, MPH, FASAM
Dr. Jawa is a clinician investigator and leader in substance use disorder research, focusing on harm reduction, addiction care, and the prevention of drug-related infections among people who use unregulated substances. Her work, supported by NIDA K12 and K23 awards, evaluates the implementation of harm reduction services and safer drug use strategies in clinical settings.
Paul J. Joudrey, MD, MPH
Dr. Joudrey's research focuses on identifying barriers to accessing person centered substance use disorder treatment across urban and rural communities.
Tamar Krishnamurti, PhD
Dr. Krishnamurti applies behavioral science, including economics principles, to substance use treatment. Her research has examined spending patterns and behavioral mechanisms that optimize treatment outcomes.
Jane Liebschutz, MD, MPH, FACP
Director, Center for for Research on Health Care
Dr. Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly, her research focuses on substance use, violence, and mental health within the practice of general medical care.
Wei-Hsuan "Jenny" Lo-Ciganic, PhD, MS, MSPharm
Dr. Lo-Ciganic's NIH-funded research focuses on overdose prediction, treatment patterns, and unsafe co-medication use, with an emphasis on applying data-driven tools to improve care for individuals with opioid and other substance use disorders.
José Giovanni Luiggi-Hernández, PhD, MPH
Dr. Luiggi-Hernández has over a decade of research experiences contributing to projects covering psychotherapy process and outcomes for both physical and mental health conditions, clinical decision-making, digital health technologies, program evluations, pre-implementation research, health disparities, social determinants of health, substsance use, and more.
Payel Jhoom Roy, MD, MSc
Clinical Director, Inpatient Substance Treatment and Recovery Service
Dr. Roy is an Internal Medicine- and Addiction Medicine-trained physician and health services researcher. Her interests are in addressing barriers to accessing medications for opioid use disorder and in developing and expanding the addiction medicine workforce.
Bryant Shuey, MD, MPH
Dr. Shuey is a board-certified internist and health services researcher whose work focuses on substance use and chronic disease, with an emphasis on evaluating policies affecting treatment access for opioid use disorder.
Gretchen White, PhD, MPH
Dr. White’s research on substance and alcohol use disorders focuses on the identification of risk factors and long-term outcomes associated with alcohol and substance use following metabolic and bariatric surgery. Her work has helped define clinically relevant thresholds for alcohol-related problems and inform postoperative care to mitigate substance-related harm in this population. She is also involved in research focusing on opioid misuse among people with metastatic cancer.
Erin Winstanley, PhD
Dr. Winstanley has 25+ years as a behavioral health services researcher and she has expertise in substsance use disorder. Her current research is focused on reducing the morbidity and mortality associated with the overdose epidemic, as well as the use of technology to improve access and quality of behavioral health services.